Emily Mullin

Wired journalist Emily Mullin examines whether neurotechnology could play a role in cancer detection and treatment. The reporting highlights startups such as Coherence Neuro, backed by venture capital from major tech companies, that are working to decode electrical signals linked to tumors. The piece raises questions about how far brain-computer interface technology could move beyond its current medical uses.